Paul J. Clancy, EVP, Chief Financial Officer at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 10,482 shares at $131.11 ($1.4M) on 2018-07-10, disclosed to the SEC on 2018-07-12.
Open-market sale of $1.4M ALXN by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.11 | 5,241 | $687K | 50.0% |
| 2 | $131.11 | 5,241 | $687K | 50.0% |
| Total | $131.11 avg | 10,482 | $1.4M | 100% |
| Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |
| BIIB | SELL | 2013-09-19 | $6.6M | — | Filing → |